Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The T-REX-Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases; an Open, Multicenter, Randomized Non-inferiority Phase 3-trial.

NCT05634889 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT05634889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05634889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The T-REX-Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases; an Open, Multicenter, Randomized Non-inferiority Phase 3-trial.
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2023
Completion date
December 31, 2033
Enrollment
1,350 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer